Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „apalutamide“
Suchtreffer
Begriffe & Kennungen
Erleada · 4.5 · The effects of CYP3A4 or CYP2C8 inducers on the pharmacokinetics of apalutamide have not been evaluated in viv
Eintrag öffnenErleada · 4.5 · The effects of CYP3A4 or CYP2C8 inducers on the pharmacokinetics of apalutamide have not been evaluated in viv
Eintrag öffnenErleada · 4.5 · The elimination of apalutamide and formation of its active metabolite, N-desmethyl apalutamide, is mediated by
Eintrag öffnenErleada · 4.5 · The elimination of apalutamide and formation of its active metabolite, N-desmethyl apalutamide, is mediated by
Eintrag öffnenErleada · 4.8 · Hypothyroidism was reported for 8% of patients treated with apalutamide and 2% of patients treated with placeb
Eintrag öffnenErleada · 4.8 · Hypothyroidism was reported for 8% of patients treated with apalutamide and 2% of patients treated with placeb
Eintrag öffnenErleada · 4.8 · In Study ARN-509-003, fracture was reported for 11.7% of patients treated with apalutamide and 6.5% of patient
Eintrag öffnenErleada · 4.8 · In Study ARN-509-003, fracture was reported for 11.7% of patients treated with apalutamide and 6.5% of patient
Eintrag öffnenErleada · 4.8 · In the SPARTAN study, with a median exposure of 32.9 months for apalutamide and 11.5 months for placebo, ischa
Eintrag öffnenErleada · 4.8 · In the SPARTAN study, with a median exposure of 32.9 months for apalutamide and 11.5 months for placebo, ischa
Eintrag öffnenErleada · 4.8 · Skin rash associated with apalutamide was most commonly described as macular or maculo-papular. Skin rash incl
Eintrag öffnenErleada · 4.8 · Skin rash associated with apalutamide was most commonly described as macular or maculo-papular. Skin rash incl
Eintrag öffnenKaletra · 4.5 · 13 In addition, co-administration of Serum concentrations of apalutamide and Kaletra may lead apalutamide may
Eintrag öffnenKaletra · 4.5 · 85 Apalutamide Apalutamide is a moderate to Decreased exposure of Kaletra may strong CYP3A4 inducer and this r
Eintrag öffnenNorvir · 4.5 · Apalutamide Apalutamide is a moderate to strong CYP3A4 inducer and this may lead to a decreased exposure of ri
Eintrag öffnenNorvir · 4.5 · Concomitant use of ritonavir with apalutamide is not recommended.
Eintrag öffnenNorvir · 4.5 · Concomitant use of ritonavir with apalutamide is not recommended.
Eintrag öffnenOrgovyx · 4.5 · An increased dose of Orgovyx is recommended if co- administration with apalutamide is required (see section 4.
Eintrag öffnenOrgovyx · 4.5 · Apalutamide Therapeutic Expected: ↓ Expected: ↓ dose for Orgovyx In a clinical study , Orgovyx 120 QD (P-gp an
Eintrag öffnenOrgovyx · 4.5 · Therapeutic dose for Apalutamide Expected: Expected: Orgovyx ↔ ↔ (CYP2C8 and CYP3A4 substrate)
Eintrag öffnen